492 related articles for article (PubMed ID: 14751815)
1. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
2. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia.
Ayyobi AF; McGladdery SH; McNeely MJ; Austin MA; Motulsky AG; Brunzell JD
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1289-94. PubMed ID: 12750118
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression.
Kissebah AH; Alfarsi S; Evans DJ
Arteriosclerosis; 1984; 4(6):614-24. PubMed ID: 6508636
[TBL] [Abstract][Full Text] [Related]
4. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
5. Lack of evidence for linkage between low-density lipoprotein subclass phenotypes and the apolipoprotein B locus in familial combined hyperlipidemia.
Austin MA; Wijsman E; Guo SW; Krauss RM; Brunzell JD; Deeb S
Genet Epidemiol; 1991; 8(5):287-97. PubMed ID: 1761202
[TBL] [Abstract][Full Text] [Related]
6. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
7. Genetic influences contributing to LDL particle size in familial combined hyperlipidaemia.
Vakkilainen J; Pajukanta P; Cantor RM; Nuotio IO; Lahdenperä S; Ylitalo K; Pihlajamäki J; Kovanen PT; Laakso M; Viikari JS; Peltonen L; Taskinen MR
Eur J Hum Genet; 2002 Sep; 10(9):547-52. PubMed ID: 12173032
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.
Packard CJ; Munro A; Lorimer AR; Gotto AM; Shepherd J
J Clin Invest; 1984 Dec; 74(6):2178-92. PubMed ID: 6511922
[TBL] [Abstract][Full Text] [Related]
10. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia.
Kissebah AH; Alfarsi S; Adams PW
Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376
[TBL] [Abstract][Full Text] [Related]
11. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
[TBL] [Abstract][Full Text] [Related]
13. Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia.
Jia L; Fu M; Tian Y; Xu Y; Gou L; Tian H; Tian L
Int J Cardiol; 2007 Sep; 120(3):331-7. PubMed ID: 17166608
[TBL] [Abstract][Full Text] [Related]
14. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies of VLDL metabolism and LDL heterogeneity.
Demant T; Packard C
Eur Heart J; 1998 Jul; 19 Suppl H():H7-10. PubMed ID: 9717058
[TBL] [Abstract][Full Text] [Related]
16. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects.
Kearney T; de Gallegos CN; Proudler A; Parker K; Anayaoku V; Bannister P; Venkatesan S; Johnston DG
Metabolism; 2003 Jan; 52(1):50-9. PubMed ID: 12524662
[TBL] [Abstract][Full Text] [Related]
17. Role of insulin resistance in familial combined hyperlipidemia.
Veerkamp MJ; de Graaf J; Stalenhoef AF
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1026-31. PubMed ID: 15731490
[TBL] [Abstract][Full Text] [Related]
18. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
[TBL] [Abstract][Full Text] [Related]
19. Catabolism of very low density lipoprotein B apoprotein in man.
Reardon MF; Fidge NH; Nestel PJ
J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554
[TBL] [Abstract][Full Text] [Related]
20. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia.
Brunzell JD; Albers JJ; Chait A; Grundy SM; Groszek E; McDonald GB
J Lipid Res; 1983 Feb; 24(2):147-55. PubMed ID: 6403642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]